Turn Therapeutics to present at Stifel forum
The company said it will present updated atopic dermatitis data and a pruritus-focused Stage 2 enrichment strategy at Stifel 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.